What is LOPJLB’s current signal on QNCX?

LOPJLB’s latest quantitative signal on Quince Therapeutics, Inc. (QNCX) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is QNCX in?

Quince Therapeutics, Inc. (QNCX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is Quince Therapeutics, Inc. based / listed?

Quince Therapeutics, Inc. is based in US, listed on NASDAQ.

Quince Therapeutics, Inc. (QNCX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$31.73+8.07%Close

SELLRECOVERY · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $9M
Beta: 1.33
P/E (TTM): -0.39

Short % float: 24.09%
Days to cover: 2.7
SI change: +19.2%

1W: +8.66%
1M: +9.56%

vs SPY 1W: +7.50%
vs SPY 1M: +6.57%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport…

Employees: 38
Headquarters: US
Founded: 2019
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 278.4K
Float: 89.4%

quincetx.com ↗

Key executives

Dirk Thye — Chief Executive Officer, Chief Medical Officer & Director

Charles S. Ryan — President

Brendan Hannah — Chief Business Officer, Chief Operating Officer, Chief Compliance Officer and Principal Financial & Accounting Officer

SEC filings

EDGAR · CIK 16627740 · QNCX

Analyst consensus

Buy

Bullish545.5%

Neutral436.4%

Bearish218.2%

L $68.00Avg $70.00H $72.00

Target$70.00+120.61%

Last$31.73

Key stats

Prediction markets

Company news